1. Home
  2. Analysis
  3. Minivelle
  4. Topiramate

Minivelle and Topiramate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Minivelle (estradiol) and Topiramate (topiramate). Common drug interactions include erythema among females.

The phase IV clinical study analyzes what interactions people have when they take Minivelle and Topiramate. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Minivelle?

Minivelle has active ingredients of estradiol. eHealthMe is studying from 3,480 Minivelle users. Check the latest studies of Minivelle.

What is Topiramate?

Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 49,809 Topiramate users. Check the latest studies of Topiramate.

On Jul, 30, 2026

20 people who take Minivelle and Topiramate together, and have interactions are studied.

Minivelle and Topiramate drug interactions.

What are the common drug interactions of Minivelle and Topiramate, by gender? *:

female:

  1. Erythema (redness of the skin)
  2. Feeling hot
  3. Nasal discomfort
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Suicidal ideation
  6. Urinary tract infection
  7. Alopecia (absence of hair from areas of the body)
  8. Cellulitis (infection under the skin)
  9. Cerebrospinal fluid leakage
  10. Constipation

male:

n/a

What are the common drug interactions of Minivelle and Topiramate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Erythema (redness of the skin)
  2. Feeling hot
  3. Skin warm
  4. Alopecia (absence of hair from areas of the body)
  5. Cellulitis (infection under the skin)
  6. Constipation
  7. Pneumonia
  8. Rib fracture
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Weight decreased

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 35.00%
  2. Immunodeficiency Common Variable: 4 people, 20.00%
  3. Immune System Disorder: 4 people, 20.00%
  4. Asthma: 3 people, 15.00%
  5. Urinary Tract Infection: 1 person, 5.00%
  6. Stress And Anxiety: 1 person, 5.00%
  7. Rosacea (a skin condition that causes facial redness): 1 person, 5.00%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.00%
  9. Irritable Bowel Syndrome: 1 person, 5.00%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Minivelle and Topiramate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Minivelle and Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Minivelle:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Minivelle and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topiramate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on estradiol and topiramate (the active ingredients of Minivelle and Topiramate, respectively), and Minivelle and Topiramate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.